Using lymphocyte markers, we confirmed the enrichment of T cells (Cd3e) (2-8 fold, Figure 3E) and B cells (~4 fold, Supplementary Figure S1C, left panel) in TILs relative to tumor tissues. Here, CD3E is linked to neoplasm.